Membrane fusions that occur during vesicle transport, virus infection, and tissue development, involve receptors that mediate membrane contact and initiate fusion and effectors that execute membrane reorganization and fusion pore formation. Some of these fusogenic receptors/effectors are preferentially recruited to lipid raft membrane microdomains. Therefore, major constituents of lipid rafts, such as stomatin, may be involved in the regulation of cell-cell fusion. Stomatin produced in cells can be released to the extracellular environment, either through protein refolding to pass across lipid bilayer or through exosome trafficking. We report that cells expressing more stomatin or exposed to exogenous stomatin are more prone to undergoing cell fusion. During osteoclastogenesis, depletion of stomatin inhibited cell fusion but had little effect on tartrate-resistant acid phosphatase production. Moreover, in stomatin transgenic mice, increased cell fusion leading to enhanced bone resorption and subsequent osteoporosis were observed. With its unique molecular topology, stomatin forms molecular assembly within lipid rafts or on the appositional plasma membranes, and promotes membrane fusion by modulating fusogenic protein engagement
soluble N-ethylmaleimide-sensitive factor-activating protein receptor (SNARE) assembly in vesicle transport, hemagglutinin in viral infection, the fusogen family of proteins (EFF-1 and AFF-1) in Caenorhabditis elegans development, and syncytin in placental morphogenesis, support the formation of hairpin structure and zippering mechanisms that are instrumental in membrane fusion (4, (7) (8) (9) (10) (11) . In addition, there is increasing evidence that lipid rafts, together with adhesion proteins and actin rearrangement, are critical for the formation and expansion of fusion pores in the final step of membrane fusion (12) (13) (14) (15) (16) .
Lipid rafts on cell membranes are microdomains with abundant cholesterol and sphingolipids. They have been demonstrated to play an important role in response to intracellular or extracellular triggering. Lipid rafts change in size and composition via clustering and partitioning (17) (18) (19) (20) . This dynamic provides a versatile platform for regulation of intermolecular interactions among receptors and effectors of opposing membranes during cell fusion. In osteoclastogenesis, disruption of lipid rafts can profoundly inhibit cell fusion in multinuclear osteoclast (OC) formation (14) . Previous findings have implied that stomatin, a major component of lipid rafts (21) , is enriched in the raft domain of the vesicular membrane, which delivers intercellular signals and promotes membrane merging (22) (23) (24) . Stomatin is a small protein (31.5 kDa) named after human hemolytic anemia hereditary stomatocytosis, and it is also called overhydrated hereditary stomatocytosis (25, 26) . The murine erythrocytes in stomatin gene-deleted mice are the same as in wild-type (WT) mice in red blood cell morphology and physiology (27) . Because of its specialized structural features, including hydrophobic domain, palmitoylation, and oligomerization (28) (29) (30) (31) , stomatin can be targeted to the membrane to regulate receptors through intermolecular action. In addition, insertion of stomatin into the membrane can create an imbalance of protein and lipid interface that reorganizes the membrane structure (32) , but the membrane topology is still uncertain (33) . During cell-cell fusion, the formation of the fusion stalk necessitates membrane bending to enter into the stage of hemifusion, and the curvature is essential for fusion pore expansion (34) . The membrane surface of stomatin-deficient erythrocytes is less curved than in normal erythrocytes (26, 35) , which may suggest that stomatin modulates membrane bending, thereby affecting the curvature of the membrane.
We addressed whether and how stomatin affects cell fusion activity by using various cell lines and microscopic approaches. Expression of stomatin and exposure to extracellular stomatin (conditioned media or recombinant protein) can induce different types of cells to form multinuclear cells (MNCs) resulting from cell-cell fusion. Stomatin knockdown leads to obvious inhibition of receptor activator of nuclear factor-kB ligand (RANKL)-induced cell fusion in OC formation and increased expression of stomatin can enhance cell fusion in murine monocytes/macrophages and promote osteoporosis. We proposed that lipid raftassociated stomatin enhances intermolecular action by clustering fusogenic assemblies, thus potentiating cell fusion and releasing the membrane-bending stresses by supplying a platform for actin polymerization to generate forces. 
MATERIALS AND METHODS

Plasmid construction and transfection
For transfection plasmid construction, the coding region from cDNA clone MGC: 9177 (BC010703), containing complete human stomatin cDNA sequence human (h)STOM, was purchased from YMGC (National Yang-Ming University Genome Research Center, Taipei, Taiwan) and cloned into pLPS-39EGFP (Clontech, Mountain View, CA, USA) or pLPS-39RFP (Clontech) expression vectors. CHO-K1 (5.0 3 10 5 ) or HEK-293T (1.0 3 10 6 ) cells were seeded in 35 mm dishes. After overnight incubation, the cells were transfected with either plasmid DNA, with T-Pro NTR-II transfection reagent (T-Pro Biotechnology, New Taipei City, Taiwan) according to the manufacturer's instructions. At 16 h after transfection, CHO GFP and CHO STOM-GFP , CHO RFP and CHO STOM-RFP , or 293T GFP and 293T STOM-GFP cells were subcultured.
Lentivirus production and transduction
Vector pLKO-AS2.puro was obtained from National RNAi Core Facility Platform (Academia Sinica, Taipei, Taiwan), and EGFP, RFP, STOM-EGFP, and STOM-RFP were amplified from expression plasmids and cloned into the lentiviral vector. In addition, the lentiviral plasmid construct of pLKO-AS2.puro-STOM contains hSTOM sequence. Gene knockdown constructs, shRNA-Luc-KD or shRNA-STOM-KD vectors, were acquired from the National RNAi Core Facility Platform; the clone numbers of shRNA-STOM-KD1 and -KD2 were TRCN0000112911 and TRCN0000112912, respectively. To generate lentiviruses, HEK-293T cells were plated in 35 mm culture dishes and transfected with lentivirus packaging plasmids: pMD.G and pCMVDR8.91 (National RNAi Core Facility Platform) and pLKO-AS2.puro expression or short hairpin (sh) RNA vectors were mixed with T-Pro NTR-II transfection reagent after overnight incubation. At 16 h after transfection, medium containing transfection reagent was replaced with 40% FBS DMEM. Medium containing lentiviruses was harvested at 40 and 64 h after transfection and used to transduce CHO-K1 (CHO STOM , CHO GFP , CHO STOM-GFP , CHO RFP , and CHO STOM-RFP ) and RAW264.7 (RAW RFP , and RAW STOM-RFP ) cells, followed by puromycin selection for 3 d. All experiments were performed in a biosafety level 2 laboratory.
Protein expression and purification
hSTOM was cloned into the pBiEx-2 vector (EMD-Millipore, Billerica, MA, USA) and expressed as N-terminal glutathione S-transferase (GST)-tagged fusion proteins (GST-STOM) in BL21-CodonPlus (DE3)-RIPL-competent cells (Agilent Technologies, Santa Clara, CA, USA). The competent cells were grown in Luria-Bertani medium with 1 mM isopropyl b-D-1-thiogalactopyranoside induction for protein expression, followed by 3 h incubation at 30°C. After induction, cells were resuspended in ice-cold PBS, or STOM-RFP-transfected CHO cells by phase-contrast and fluorescence microscopy. Scale bar, 50 mm. C ) The CHO STOM-RFP cells entering mitosis at time 0 (arrow) were noted to stop at cytokinesis (from 01:48:00 to 03:00:00). As a result of cytokinesis failure, 2 putative daughter cells (arrowheads) refused and formed a cell containing 2 nuclei (double arrowhead). D) Two independent CHO STOM-GFP cells (arrowheads) came into contact, interacted, and fused into a cell with 2 nuclei (double arrowhead). E ) CHO cells separately transduced by lentiviral vector to express STOM-GFP (CHO STOM-GFP ) or STOM-RFP (CHO STOM-RFP ) were cocultured for 3 d. Cells having both green and red fluorescence (appear yellow), indicative of cell fusion, were identified by confocal microscopy (arrowheads) and quantified as percentage of fused cells (n = 2445 total counted cells). Cocultured CHO cells transduced with GFP or RFP were used as controls (n = 2808 total counted cells). Scale bar, 75 mm. All data are means 6 SD from 3 independent experiments. *P , 0.05, **P , 0.01, by paired Student's t test. Figure 2 . Extracellular stomatin affects other cells. A) CMpro CHO STOM-GFP and CMpro CHO GFP [CM from CHO cells transfected with STOM-GFP ( pro CHO STOM-GFP ) or control GFP ( pro CHO GFP ) gene] were subjected to fluorophotometry analysis. Note the progressive increase of fluorescence over time in CMpro CHO STOM-GFP compared to CMpro CHO GFP cells, indicating detection of released stomatin by pro CHO STOM-GFP cells. Data are means 6 SD from 5 independent experiments (each with 3 technical replicates). ***P , 0.001, by 2way ANOVA. B) Samples of CHO cells transduced with stomatin ( pro CHO STOM ) or control vector ( pro CHO), TCA-precipitated proteins (CM of CMpro CHO STOM or CMpro CHO, respectively), and collected exosomes from 3 d culture media were subjected to Western blot analysis. hSTOM proteins were present not only in pro CHO STOM cells, but also in their extracellular culture media. b-Tubulin was not detected in CM. HSP90 protein was an exosomal marker (n = 5 independent experiments). C) pro CHO or pro CHO STOM cells were seeded in the upper chamber of a cell migration assay system (0.4 mm-sized pores) and protein receiver rec CHO cells were plated in the lower chamber. After 3 d, rec CHO cells were subjected to immunofluorescence staining and Western blot to reveal uptake of stomatin by rec CHO. A representative example is shown (n = 5 independent experiments.) Scale bar, 50 mm. D) CM of CMpro CHO STOM or CMpro CHO cells, bacteria-expressed recombinant protein GST, or stomatin conjugated with GST (GST-STOM) was added to mixed cultured cells separately labeled with either CellTracker Red or CellTracker Green. After . Stomatin is involved in osteoclastogenesis. A) Samples of RANKL-treated or untreated RAW cells, and exosomes from culture media were subjected to Western blot analysis. RANKL stimulation increased DC-STAMP expression in a time-dependent manner. mStom proteins were increased in both cell lysates and extracellular exosomes from d 1 to 7 during RANKL treatment. GAPDH was used as the loading control and HSP90 as an exosomal marker (n = 5 independent experiments). B) Localization of mStom (Cy5 conjugation; green) and DC-STAMP (tetramethylrhodamine conjugation; red) in RANKL-treated or untreated RAW cells was analyzed by immunofluorescence assay with DNA labeling (blue). RANKL-induced RAW cells displayed a (continued on next page) passed through a French press, and centrifuged at 15,000 g for 10 min at 4°C. The supernatant was purified with GSTrap FF columns with a GST buffer kit (GE Healthcare Life Science, Pittsburgh, PA, USA), according to the manufacturer's protocol. The proteins were concentrated by using Amicon Ultra-15 with Ultracel-30 membrane (EMD-Millipore). Cell fusion was examined with 100 mg/ml protein (0.5 mg/ml). 
Cell multinucleation and fusion analysis
CHO
Conditioned medium preparation and treatment
Conditioned medium (CM) from protein-expressing cells (producers) pro CHO GFP (pLPS-39EGFP) or pro CHO STOM-GFP (pLPS-STOM-39EGFP) cells was collected and passed through a 0.20 mm filter (EMD Millipore) to remove cell debris for analysis of extracellular protein stomatin-GFP on a fluorescence microplate reader with excitation 480 nm and emission 520 nm (Infinite200; Tecan, Männedorf, Switzerland). Three-day culture medium (F12 supplemented with 1% L-glutamine) from the lentiviral transduced clones pro CHO (pLKO-AS2.puro) or pro CHO STOM (pLKO-AS2.puro-STOM) cells (producers) was collected, filtered (0.20 mm), and subjected to trichloroacetic acid (Sigma-Aldrich, St. Louis, MO, USA) precipitation, to concentrate the proteins for Western blot analysis. To reveal CM-induced MNCs, Transwell cell-migration assay plates (pore size, 0.4 mm; EMD-Millipore) were used to coculture receiver cells ( rec CHO) in the bottom chamber and seeding either pro CHO or pro CHO STOM cells in the upper chamber for 3 d. To investigate cell fusion, the cells were labeled with CellTracker Green CMFDA or CellTracker Red CMTPX in a 10 mM working concentration (Thermo Fisher Scientific) with CM treatment. The total exosomes were purified with Total Exosome Isolation reagents (Thermo Fisher Scientific), according to the manufacturer's protocol.
Western blot analysis
Cells and exosomes were lysed with RIPA solution supplemented with protease inhibitor cocktail (EMD-Millipore). Proteins were separated on SDS-polyacrylamide gels and then transferred by SDS-PAGE onto PVDF membranes (EMD-Millipore). After they were blocked with 5% bovine serum albumin (BSA) in Tris-buffered saline-0.1% Tween 20 (TBS-T) at room temperature for 1 h, the membranes were incubated with anti-hSTOM (dilution: 1:500; M-14; Santa Cruz Biotechnology, Dallas, TX, USA), anti-mStom (dilution: 1:500; N-14; Santa Cruz Biotechnology), anti-dendritic cell-specific transmembrane protein (anti-DC-STAMP; dilution: 1:200; 1A2; EMD-Millipore), anti-heat shock protein (HSP)90a (dilution 1:3,000; EMD-17D7; EMD-Millipore), anti-GAPDH (dilution: 1:10,000; Sigma-Aldrich), or anti-tubulin (dilution: 1:10,000; Sigma-Aldrich) antibodies at 4°C overnight. The membranes were washed 3 times for 10 min each with TBS-T and then incubated with appropriate horseradish peroxidase-conjugated secondary antibodies (dilution: 1:5000; Santa Cruz Biotechnology) for 1 h at room temperature. Western blot signals were visualized with SuperSignal West Femto Maximum Sensitivity Substrate (Thermo Fisher Scientific) and imaged with ImageQuant LAS-4000 (GE Healthcare Life Science).
Immunofluorescence staining
Cells seeded on coverslips were fixed with 3.7% formaldehyde (Sigma-Aldrich) at room temperature for 15 min and then rinsed twice with PBS for 5 min. After fixation, the cells were permeabilized with 0.01% TX-100 for 5 min, washed 3 times with PBS for 5 min each, and blocked with 5% BSA blocking solution for 60 min. Permeabilized cells were probed with the appropriate dilution (1:200) of antibodies: anti-hSTOM (M-14), anti-mStom (N-14), and anti-DC-STAMP (1A2) in blocking solution overnight, in a humid chamber at 4°C. The cells were then washed 3 times in PBS for 10 min each and incubated with fluorophore-conjugated (dilution: 1:500; AlexaFluor-488, tetramethylrhodamine, or Cy5) secondary antibodies (Jackson ImmunoResearch, West Grove, PA, USA) in blocking solution for 1 h at room temperature. The cell samples were labeled with Hoechst 33342 to mark nuclei, mounted with anti-photobleaching medium, and observed by confocal microscopy (SP5; Leica). For analysis of colocalization of mStom and DC-STAMP, MetaMorph Software was used to calculate the area that had been selected above the threshold in 3 pixels of colocalized signals. The lipid rafts were labeled with a Vybrant AlexaFluor-488 Lipid Raft Labeling Kit (Thermo Fisher Scientific). phosphocholine) (1:4 weight ratio, 5 mg/ml) dissolved in n-hexane at 1 mg/ml was painted onto the aperture in a Delrin cup (diameter of aperture, 150 mm) and dried under N 2 . In consecutive steps, 5 ml stock solutions of recombinant proteins (GST and GST-STOM; 0.5 mg/ml) were added to the Delrin cup and dried under N 2 . The Delrin cup was then inserted into the cup holder, and both reservoirs were filled with 1 ml of buffer (300 mM KCl, 5 mM HEPES; pH 7.2). Then the lipid/protein mixture was painted with a brush across the aperture under a constant voltage of 80 mV, to support membrane association (36) . Experimental data were recorded at room temperature with a planar lipid bilayer workstation (Warner Instruments, Hamden, CT, USA), with a BC-353 amplifier and 1440A data-acquisition system. Records were recorded at 5 kHz and filtered at 10 Hz with a Bessel 8-pole low-pass filter.
Planar lipid bilayer workstation
STOM-Tg mouse generation and m-CT analysis
hSTOM was cloned into vector STO-p1033 [modified and kindly provided by Dr. Ting-Fen Tsai, Institute of Genome Sciences, National Yang-Ming University) (37)] to drive stomatin gene expression by the RNA polymerase II large subunit promoter. Stomatin transgenic (STOM-Tg) mice were generated by pronuclear microinjection into C57BL/6 fertilized eggs. Tail DNA was used to examine genotype of mice by PCR. To analyze the murine physiology, a microcomputed tomography (m-CT) scanner (SkyScan 1076; Bruker, Kontich, Belgium) was used at the Taiwan Mouse Clinic (Academia Sinica), to acquire data and 3-dimensional (3D) images from cortical and spongy bone of femurs of 76-wk-old male WT (n = 3) and STOM-Tg (n = 3) mice and 12-or 34-wk-old female WT (n = 8) and STOM-Tg (n = 8) mice. For cortical bone porosity or trabecular bone analysis and 3D images, a m-CT scanner was operated at 50 kV, 140 mA, 0.8°r otation steps, 0.5 mm Al filter, and 9 mm image pixel size of scan resolution. Cross-sections were reconstructed with a cone-beam algorithm (NRecon software; Bruker). File data sets were then imported into CTAn software (Bruker) with a region of interest of 1.5 mm that was 0.4 mm away from the growth plate level in the direction of the metaphysis, to calculate 3D analysis and image generation.
BMDC preparation and osteoclastogenesis
The BMDCs were acquired from femurs of the C57BL/6 WT or STOM-Tg mice. RPMI1640 medium (HyClone) containing 10% FBS, 1% penicillin-streptomycin liquid (HyClone), and 30 ng/ml macrophage-colony stimulating factor (M-CSF; PeproTech, Rocky Hill, NJ, USA) was used to culture 1. 
RESULTS
Increased expression of stomatin causes MNC formation resulting from cell-cell fusion
The human stomatin gene (STOM) tagged with GFP or the GFP gene alone was engineered and transfected into CHO K1 cells, generating CHO STOM-GFP and CHO GFP cells, respectively. After 3 d of culture, we noted that the number of MNCs (Fig. 1A) was significantly increased in CHO STOM-GFP cells that expressed a high level of stomatin compared with control CHO GFP cells. Some MNCs contained 2 nuclei per cell, whereas others had 3 or more nuclei ( Fig. 1A ; quantified in Fig. 1B ). Furthermore, MNC formation increased over time (Supplemental Fig. 1A ), typically reaching a 3-fold increase compared to the control group in 3 d. A high content of stomatin induced MNC formation, not only in CHO cells but also in human embryonic kidney (HEK) 293T cells (Supplemental Table 1 ). Time-lapse images were obtained to record the process of MNC formation. In one series of events exemplified in Fig.  1C , in a cell undergoing cell division (1:00:00-1:48:00) mitosis was noted to stop (1:48:00 ; 3:00:00), and the cell then went through cytokinesis failure or refusion (38) (3:00: 00-3:54:00) to form a double-nuclear cell. In another series of events exemplified in Fig. 1D, 2 adjacent cells were noted to come into contact and then to undergo cell fusion 
Exogenous stomatin also induces cell-cell fusion
It is generally thought that stomatin associates with the inner leaflet of the lipid bilayer via palmitoylation modification and hydrophobic domain (28, 29) . Given such molecular characteristics, it is interesting to note that stomatin produced in the cells can be detected in the extracellular environment. The release and accumulation of extracellular stomatin in CMpro CHO STOM-GFP increased over time ( Fig.  2A) . In contrast, little GFP protein was detected in CMpro-CHO GFP . Western blot analysis revealed that hSTOMs were found, not only in the lysates from cells producing stomatin ( pro CHO STOM ), but also in the extracellular culture medium (or CM, CMpro CHO STOM ) and exosomes (Exosome-pro CHO STOM ) (Fig. 2B) . Although the mechanism for stomatin secretion is not clear, we speculate that stomatin found in the CM was not related to lysis of cells, because tubulin was not detected. We then examined whether the extracellular stomatin was functional. To do so, pro CHO STOM or pro CHO (control) cells were plated on the top insert of a Transwell cell-migration culture chamber (Fig. 2C ). We found that stomatin proteins released by pro CHO STOM cells diffused across the permeable membrane to reach the bottom chamber, where extracellular stomatin could bind to or be internalized by rec CHO cells seeded in the bottom chamber, as evidenced by immunofluorescence and Western blot assay (Fig. 2C) . In another series of experiments, purified recombinant stomatin produced by Escherichia coli or filtered CMpro CHO STOM was applied to CHO cells for functional testing. After 3 d, both treatments effectively produced MNCs (Supplemental Table 1 ) formed via cell fusion (Fig. 2D) . These results support the notion that stomatin proteins can be released by the cells selectively expressing the stomatin gene, and the extracellular stomatin can affect cells in their surroundings.
Stomatin affects MNC formation but not TRAP expression during RANKLmediated osteoclastogenesis
Treating murine RAW cells with RANKL induced TRAP expression and MNC formation, given that these macrophage/monocyte cells progressively differentiated into OCs (2, 39) . We speculated whether stomatin was involved in such processes. To address this question, we performed Western blot analysis to determine murine stomatin (mStom) and DC-STAMP expression during RANKL treatment (Fig. 3A) . Stimulating RAW cells with RANKL up-regulated the expression of DC-STAMP, a membrane protein essential for cell fusion during osteoclastogenesis (2, 40) , and of mStom. Much more abundant mStom was found on the released exosomes from RANKL-treated RAW cells. In addition, immunofluorescence analysis of mStom and DC-STAMP distribution after RANKL treatment indicated obvious colocalization of mStom with DC-STAMP in cell-cell contact sites (Fig. 3B) , more extensive in RANKL-treated RAW cells compared to the control, and part of the stomatin was on the lipid rafts (Supplemental Fig. 2 ). Moreover, 2 shRNAs (STOM-KD1 and -KD2) against different target sites of stomatin were individually introduced through lentiviral particles into RAW cells (RAW STOM-KD1 and RAW STOM-KD2 ). Both constructs effectively down-regulated stomatin expression in RAW cells, with STOM-KD2 (;80%) appearing to be more potent than STOM-KD1 (;70%) ( Fig 3C) . Such a RANKL-mediated DC-STAMP increase was profoundly inhibited in RAW STOM-KD1 or RAW STOM-KD2 cells by stomatin knockdown, compared to the control RAW Luc-KD cells. In the control, RANKL treatments also caused RAW cells to form MNCs (Fig. 3D) ; thus, RANKL-induced cell fusion was inhibited by stomatin knockdown treatments, with STOM-KD2 appearing to be more potent than STOM-KD1 ( Fig. 3D ; quantified in Fig. 3E ). Production of TRAP after RANKL treatment was not inhibited by stomatin down-regulation ( Fig. 3D) . Although RAW STOM-KD1 or RAW STOM-KD2 cells remained mononuclear after RANKL stimulation, most if not all of them became TRAP + . In contrast, transduction of stomatin into RAW STOM-RFP cells caused them to undergo cell fusion, forming MNCs in the absence of RANKL ( Fig. 4A; quantified in Fig. 4B) ; however, most of the resulting MNCs remained TRAP 2 . The control RAW RFP cells were mostly mononuclear and TRAP 2 (Fig. 4A) , without RANKL stimulation. Occasionally, there were clusters of TRAP + cells found in both control RAW RFP and RAW STOM-RFP cells (Fig. 4B) ; the occurrences of TRAP + cells were probably caused by trimerization of RANK receptor (41) . Such findings indicate that stomatin is crucial for MNC formation in osteoclastogenesis; nevertheless, TRAP activity may not be related to the stomatin expression level.
Increased stomatin expression induces an osteoporosis phenotype in mice
STOM-Tg mice were generated to reveal the role of stomatin in animals. Analysis by m-CT showed that porosity of cortical bone was significantly higher in STOM-Tg mice than in WT mice ( Fig. 4C and Table 1 ). In addition, examination of the spongy bone in the femur according to various parameters, such as bone volume (bone volume/total volume; BV/TV), trabecular bone (Tb) thickness (Th), Tb number (No), and Tb separation (Sp), demonstrated an osteoporosis phenotype in STOM-Tg mice, compared to the WT (Fig. 4D and Table 1 ). BMDCs from WT and STOM-Tg mice were also obtained and subjected to RANKL stimulation. We found that the basal level of DC-STAMP and RANKL-induced DC-STAMP increase were both higher in STOM-Tg BMDCs than in WT BMDCs (Supplemental Fig. 3A) . Microscopic examination after a TRAP staining assay demonstrated that STOM-Tg BMDCs gave rise to more TRAP + MNCs (or OCs) after RANKL treatment than WT BMDCs (Supplemental Fig. 3B ). These results support the notion that high-level expression of stomatin in STOM-Tg mice promotes differentiation and cell fusion of OCs, resulting in enhanced bone resorption and an osteoporosis phenotype. 
Stomatin disturbs membrane integrity
Next, to explore the effect of stomatin on the membrane, the recombinant protein stomatin was expressed in E. coli, purified, and reconstituted into lipid membranes. Under constant-voltage conditions, stomatin rendered the membrane permeable to ions (Fig. 5A) . Several conductance levels in the range of 50-90 pS were detected. The events lasted over several seconds. Occasionally, protein assemblies appeared to switch between the 2 levels, directly and dynamically. As a control, GST from vector did not exhibit any membrane activity (Fig. 5B) . These results indicate that stomatin, by forming dynamic assemblies, can disturb the membrane and enable ion flux across it.
DISCUSSION
A schematic model illustrating proposed roles of stomatin for cell fusion during osteoclastogenesis is shown in Fig. 6 .
Stomatin is an integral membrane protein (21) that is widely expressed in many cell types and is associated with lipid rafts (23, 24, 42) . It is generally accepted that stomatin has a unique hairpin-loop topology (32, 43) . It contains a hydrophobic domain toward its N terminus (43) . This motif, together with several palmitoylation sites flanking the hydrophobic domain (28, 29) , helps anchor the molecule to the inner leaflet of the lipid bilayer. Both the N and C termini of stomatin face the cytoplasm (32, 33) . In such a scenario, stomatin synthesized in the cytoplasm can be translocated either by diffusion ( Fig. 6, 1) or through vesicular transport (Fig. 6, 19) to the plasma membrane with a predicted signaling peptide sequence (44) . The membrane-associated stomatin proteins are present in high abundance within lipid rafts, the sphingolipid-and cholesterol-rich membrane microdomains that preferentially contain lipid-modified proteins (21) . In addition to the hairpin-loop topology, stomatin may exist as a singlepass transmembrane structure with intracellular N terminus and extracellular C terminus (33) . In this topology, transmembranous stomatin proteins can also translocate to the plasma membrane via a conventional secretory pathway ( Fig. 6, 19) . Experimental evidence supports the notion that both topologies coexist through differential folding of stomatin. In this study, we found that intracellular stomatin can be released into the extracellular environment. It is unclear whether and how stomatin, in either the inner leaflet membrane-anchored proteins or single-pass transmembrane protein form, is released into the culture medium ( Fig. 6, 2 ; see Fig. 2A, B) . Equally unclear is how the released free stomatin outside of a cell is internalized by another cell (Fig. 6, 3 ; see Fig. 2C ). A recent study of exosomes, a special category of extracellular vesicles (45), provides a possible mechanism for stomatin secretion and uptake. In biologic fluids, including cultured medium, the cell-derived exosomes are smaller than the pore size of a Transwell cell-migration membrane and cannot be excluded by filtering CM ( Fig. 2A-C) . We observed that extracellular stomatin was present in exosomes (Figs. 2B and 3A), which are released from the cell when multivesicular bodies (MVBs) containing stomatin fused with the plasma membrane ( Fig. 6, 29) (22, 45) . Extracellular exosomes carrying various proteins can fuse with target cell membranes, either directly with the plasma membrane or with the endosomal membrane after endocytosis. Exosomes can thus transfer molecules, such as stomatin, from one cell to another via membrane vesicle trafficking ( Fig. 6, 39 ; see Fig. 2C ). After entering the target cell, the cytoplasmically oriented integral membranous stomatin may form high-order oligomers within lipid rafts (Supplemental Fig. 2 ) and execute its functions (Fig. 6, 4) (30, 31) . The plasma membrane is highly mosaic, with different lipid and protein levels in the dynamics and the clusters of variable sizes; the lipid rafts represent one such example. Within the lipid rafts, the spatial and temporal heterogeneity can be further modulated by the interplay among lipids and proteins. We hypothesize that stomatin oligomers, by restricting lateral diffusion or "corralling" membrane proteins within the lipid rafts, affect the intermolecular actions of membrane receptors and their ligands or effectors, to regulate downstream signal transduction (Fig. 6, 4) . Figure 6 . Schematic model illustrating proposed roles of stomatin for cell fusion during osteoclastogenesis. A schematic model illustrating a hypothetic model for the release of stomatin and uptake through membrane anchor (1→2→3), extracellular vesicle, or exosome pathway (19→29→39) and its corralling role in the lipid raft membrane microdomains (4) that enhances intermolecular interactions between fusogenic DC-STAMP and other putative fusogens (5) . In this scenario, stomatin can potentiate cell fusion activity triggered by RANKL stimulation (a) during osteoclastogenesis, without affecting TRAP expression (b). See text for details. Nu, nucleus; OCP, osteoclast progenitor; mOC, mononuclear osteoclast; OC, multinuclear osteoclast. MVB, multivesicular body; lipid rafts, membrane labeled red.
The role of stomatin in cell fusion was tested by an osteoclastogenesis model. Treating OC progenitor (OCP) cells with M-CSF/RANKL turned mononuclear TRAP 2 OCPs into TRAP + mononuclear (m)OCs. Further RANKL treatment of mOCs triggered cell fusion, forming multinuclear TRAP + mature OCs. As shown in Fig. 6 , binding of RANKL to RANK receptors on RAW cells (Fig. 6, a) activated NFATc1 transcription factor to turn on TRAP expression (b) and increased expression of DC-STAMP (c) (39, 40) . Interactions of DC-STAMP and possibly other fusogenic molecules (fusogen in Fig. 6 ) residing on the plasma membrane trigger fusion at the site of intercellular contact. We hypothesize that such intermolecular interactions between cells are facilitated by stomatin oligomers that enhance membrane fusion complex formation within the lipid rafts ( Fig. 6, 5 ; see Fig. 3B and Supplemental Fig. 2) , and the molecular complex forms a zippering or hairpin structure that bends membrane to induce fusion pore expansion, as a prelude to cell fusion (Fig. 6, 6) . Therefore, we propose that stomatin does not initiate cell fusion, but instead works as an "enhancer" to potentiate cell-fusion events. This notion is supported by the finding that a decrease in stomatin hindered DC-STAMP-mediated cell fusion but not TRAP expression in RANKL-stimulated RAW cells, resulting in formation of TRAP + mononuclear cells (Fig. 3D) . In contrast, an increase in stomatin causes RAW cells to fuse, even in the absence of RANKL stimulation, resulting in the formation of TRAP 2 MNCs (Fig. 4A ). Occasionally, physiologic-level RANK receptors on RAW cells can spontaneously trimerize to trigger low-level signaling and induce TRAP synthesis but not cell fusion ( Fig. 6a9) (41) , resulting in formation of TRAP + mononuclear cells (see Fig. 4A, b) .
In terms of molecular property, stomatin may not serve as the receptor that initiates the cell fusion process for small proteins (31.5 kDa). It is also not likely that stomatin can function as an effector that mediates hemifusion and fusion pore formation. Our data support the notion that high content of stomatin increases effectiveness of molecular machinery for cell fusion by recruiting existing fusogenic receptor/effectors to the (lipid rafts) sites of cell-cell contact and enhance their interactions. The unique protein refolding property of stomatin between the hairpin and single-pass transmembrane topology offers 2 implications: on the one hand, stomatin, through the corralling effect, can facilitate interactions among fusogenic proteins, either within the membrane microdomain or across the appositional membranes. On the other hand, it may help relieve the membrane curvature stress by increasing permeability (Fig. 5A) (35) and cause clustering of the fusogenic molecular assembly to the cortical actin cytoskeleton, as either a rigid supportive platform (Fig. 6, 6) or a tethered site for actin polymerization that generates force to drive expansion of fusion pores.
We have shown in STOM-Tg mice that, through overactive osteoclastogenesis, a high level of stomatin leads to an osteoporosis phenotype (Fig. 4C, D) . Differentiation and maturation of OCs are characterized by both MNC formation and synthesis of bone-resorbing enzymes. The finding that stomatin regulates cell fusion without interfering with enzyme production may provide new opportunities for correcting bone loss disorders by inhibiting the molecular events associated with membrane fusion.
